相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis
Mengying Hu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma
Zhuo Yu et al.
ACS NANO (2020)
Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
Jianfeng Guo et al.
ACS NANO (2020)
Membrane-core nanoparticles for cancer nanomedicine
Jianfeng Guo et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer
Yue Guan et al.
FRONTIERS IN ONCOLOGY (2020)
Tackling TAMs for Cancer Immunotherapy: It's Nano Time
Yishun Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Enhanced Wound Healing via Collagen-Turnover-Driven Transfer of PDGF-BB Gene in a Murine Wound Model
Raj Kumar Thapa et al.
ACS APPLIED BIO MATERIALS (2020)
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Yun Liu et al.
THERANOSTICS (2020)
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice
Xue Luan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Xiaopin Duan et al.
NATURE COMMUNICATIONS (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
Engineering nanoparticles to locally activate T cells in the tumor microenvironment
Dangge Wang et al.
SCIENCE IMMUNOLOGY (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen et al.
ADVANCED MATERIALS (2019)
DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers
Juan Ruiz-Banobre et al.
GASTROENTEROLOGY (2019)
Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer
Manisit Das et al.
MOLECULAR THERAPY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Design of 5-fluorouracil (5-FU) loaded, folate conjugated peptide linked nanoparticles, a potential new drug carrier for selective targeting of tumor cells
Julekha Kazi et al.
MEDCHEMCOMM (2019)
Nanocarrier-based systems for targeted and site specific therapeutic delivery
Joydeb Majumder et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model
Mohamed A. Safwat et al.
MOLECULAR PHARMACEUTICS (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer
Campbell S. Roxburgh et al.
ONCOIMMUNOLOGY (2018)
Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers
Limei Shen et al.
ACS NANO (2018)
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
Wantong Song et al.
ADVANCED MATERIALS (2018)
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Hanyong Sun et al.
NATURE COMMUNICATIONS (2018)
Immunogenic effects of chemotherapy-induced tumor cell death
Yi-Jun Wang et al.
GENES & DISEASES (2018)
Cancer nanomedicines: oversold or underappreciated?
Roy van der Meel et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
Lifang Cheng et al.
MOLECULAR THERAPY (2017)
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
Giovanni Germano et al.
NATURE (2017)
Bridging Bio-Nano Science and Cancer Nanomedicine
Mattias Bjornmalm et al.
ACS NANO (2017)
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Anne Showalter et al.
CYTOKINE (2017)
Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival
Tyler J. Goodwin et al.
BIOMATERIALS (2017)
Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles
Kaili. Hu et al.
ACS NANO (2017)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Bengt Gustavsson et al.
CLINICAL COLORECTAL CANCER (2015)
Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy
Shutao Guo et al.
BIOMATERIALS (2014)
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
John C. Castle et al.
BMC GENOMICS (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
Yuan Zhang et al.
BIOMATERIALS (2013)
Cytokine-Mediated Programmed Proliferation of Virus-Specific CD8+ Memory T Cells
Hans-Peter Raue et al.
IMMUNITY (2013)
Bevacizumab in Stage II-III Colon Cancer: 5-Year Update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Shukui Qin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Turning an antiviral into an anticancer drug: Nanoparticle delivery of acyclovir monophosphate
Jing Yao et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
Yuan Zhang et al.
MOLECULAR THERAPY (2013)
Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice
Jianfeng Guo et al.
BIOMATERIALS (2012)
Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
Frank A. Sinicrope et al.
CLINICAL CANCER RESEARCH (2012)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery
Jun Li et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Effect of new hydrophobic modification of hyaluronan on its solution properties: evaluation of self-aggregation
Martin Chytil et al.
CARBOHYDRATE POLYMERS (2009)
Apoptosis and glutathione: beyond an antioxidant
R. Franco et al.
CELL DEATH AND DIFFERENTIATION (2009)
S-1: a promising new oral fluoropyrimidine derivative
Muhammad Wasif Saif et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Regulation of glutathione synthesis
Shelly C. Lu
MOLECULAR ASPECTS OF MEDICINE (2009)
Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
Su Li et al.
BMC CANCER (2008)
IL-12-programmed long-term CD8+ T cell responses require STAT4
Qingsheng Li et al.
JOURNAL OF IMMUNOLOGY (2006)
OPTIMOX1:: A randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer -: A GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies
H Kasuya et al.
CANCER RESEARCH (2005)
Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells
R Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Regulation of T cell immunity by dendritic cells
A Lanzavecchia et al.
CELL (2001)
Role of reactive oxygen species (ROS) in apoptosis induction
HU Simon et al.
APOPTOSIS (2000)
分享论文
